RareCan appoints Dr Anita Cooper as Non-Executive Director

pharmafile | August 25, 2021 | Appointment | Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing  

Cancer research company RareCan has appointed Dr Anita Cooper as Non-Executive Director.

Cooper has over 30 years’ experience in global business and is currently a Non-Executive Director for Simbec-Orion, a leading Clinical Research Organisation.

Piers Kotting, CEO of RareCan, commented: “We are thrilled to welcome Anita to the Board of RareCan. Anita’s wealth of industry experience will help us to accelerate rare cancer research by maximising the value of RareCan to both the global life sciences and pharmaceutical services industries.”

Related Content

No items found

Latest content